DOC monthly performance report
View DOC's monthly returns, drawdown, and seasonality trends — updated every month.
DOC monthly report
—
Key takeaways
- Healthpeak Properties (DOC) closed November 2026 at $19.98, up 4.99% for the month and +14.11% over the trailing 12 months.
- Year-to-date, DOC is +24.25%, outperforming the S&P 500 which has returned +10.62% YTD.
- The stock is trading +3.86% versus its 200-day moving average ($19.24), a bullish technical signal.
- Over the past three years, DOC has underperformed the S&P 500 by −43.05%, with a relative strength index reading of 74.9.
- Win rate over the trailing 39 months stands at 46.2% — 18 positive months versus 21 negative months.
Healthpeak Properties ended November 2026 at $19.98, posting a monthly return of +4.99%. The S&P 500 returned −0.18% over the same window, leaving relative performance at +5.17%.
The current quarter stands at +0.05% (Q4 2026 (QTD)), while medium-term trend remains constructive: price is +3.86% versus the 200-day moving average ($19.24).
Year-to-date, DOC is +24.25% against SPY +10.62%, a gap of +13.63%. The stock is currently −12.94% below its 52-week high, with maximum 3-year drawdown at −31.75%.
| Period | DOC | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | −0.70% | −0.36% | −0.33% |
| 1 Week | −1.38% | +2.59% | −3.98% |
| 1 Month | +4.99% | −0.18% | +5.17% |
| 3 Months | −2.92% | −2.37% | −0.55% |
| 6 Months | +2.15% | +0.83% | +1.32% |
| YTD | +24.25% | +10.62% | +13.63% |
| 12 Months | +14.11% | +12.25% | +1.86% |
| 3 Years | +28.32% | +71.37% | −43.05% |
| Rank | Month | Return |
|---|---|---|
| #1 | May 2026 | +18.43% |
| #2 | Dec 2023 | +14.32% |
| #3 | Mar 2024 | +11.94% |
| #4 | Jun 2026 | +11.75% |
| #5 | Nov 2023 | +11.38% |
| Rank | Month | Return |
|---|---|---|
| #1 | Oct 2023 | −15.31% |
| #2 | Dec 2025 | −11.94% |
| #3 | Apr 2025 | −11.77% |
| #4 | Sep 2023 | −10.79% |
| #5 | Feb 2024 | −9.46% |
| Quarter | Return |
|---|---|
| Q3 2025 | +9.37% |
| Q4 2025 | −16.03% |
| Q1 2026 | +2.18% |
| Q2 2026 | +30.25% |
| Q3 2026 | −6.68% |
| Q4 2026 (QTD) | +0.05% |
| Year | Return |
|---|---|
| 2023 | −21.02% |
| 2024 | +2.37% |
| 2025 | −20.67% |
| 2026 | +24.25% |
| Metric | Value |
|---|---|
| 52-Week High | $22.95 (2026-07-28) |
| 52-Week Low | $15.71 (2025-12-23) |
| Current Price | $19.98 |
| 200-Day Moving Average | $19.24 |
| Price vs 200DMA | +3.86% |
| 3-Year Maximum Drawdown | −31.75% (2025-12-23) |
| Current Drawdown from 52W High | −12.94% |
| RS metric | Value |
|---|---|
| RS Index (3-year, rebased to 100) | 74.9 |
| 3-Year Excess Return vs S&P 500 | −43.05% |
| RS Peak | 123.6 (Jan 2024) |
| RS Trough | 63.5 (Apr 2026) |
| Status | Underperforming Benchmark |
Frequently asked questions
What was DOC's return for this report period?
DOC returned +4.99% in the latest monthly window ending 2026-11-13.
Has DOC outperformed SPY year to date?
YTD DOC: +24.25% vs SPY: +10.62%.
What is DOC's 12-month return?
+14.11% over the trailing 12 months.
Is DOC above or below its 200-day moving average?
Price is +3.86% versus 200DMA ($19.24).
What is the maximum drawdown in the 3-year window?
−31.75% on 2025-12-23.